The Fobi ring gastric sleeve is a specialised bariatric procedure that combines a standard sleeve gastrectomy with the addition of a fixed silicone ring around the upper stomach, designed to enhance and sustain long-term restriction. As obesity surgery continues to evolve in the UK, this banded variant has attracted interest as a potential solution to one of sleeve gastrectomy's recognised limitations: gradual sleeve dilation and associated weight regain. This article explains how the procedure works, how it differs from standard sleeve gastrectomy, who may be eligible under NHS and NICE guidance, what risks and benefits to expect, and what recovery and long-term follow-up involve.

What Is a Fobi Ring Gastric Sleeve Procedure?

The Fobi ring gastric sleeve combines sleeve gastrectomy with a fixed silicone ring placed around the upper stomach to create additional restriction and slow food passage, reducing hunger via ghrelin suppression alongside volume restriction.

Have any more questions about this? Message our pharmaceutical team to get more info →

The Fobi ring gastric sleeve is a bariatric surgical procedure that combines sleeve gastrectomy with the addition of a fixed, non-adjustable silicone ring — known as a Fobi ring or banded ring — placed around the upper portion of the newly formed gastric sleeve. This is distinct from an adjustable gastric band. The procedure was developed as a modification of existing weight-loss surgery techniques, with the aim of enhancing and sustaining long-term restriction of food intake.

During a standard sleeve gastrectomy, approximately 75–80% of the stomach is removed, leaving a narrow, tube-shaped stomach. In the Fobi ring variant, a soft silicone ring is positioned around the sleeve, typically at a point roughly 3–5 cm below the gastro-oesophageal junction, though the precise position varies by surgeon and centre. This ring creates an additional point of resistance, slowing the passage of food through the upper stomach and prolonging the sensation of fullness.

It is also worth noting that sleeve gastrectomy reduces circulating levels of ghrelin — a hunger-stimulating hormone — which contributes to appetite suppression and weight loss beyond simple restriction of stomach volume.

The procedure is performed laparoscopically (keyhole surgery) under general anaesthesia and typically takes between 60 and 120 minutes. It is considered primarily a restrictive procedure — meaning it works mainly by limiting the volume of food the stomach can hold — rather than significantly altering nutrient absorption. By contrast, the Roux-en-Y gastric bypass (RYGB) combines restriction with both limited malabsorptive and significant metabolic and hormonal effects. The Fobi ring modification is intended to address one of the recognised limitations of standard sleeve gastrectomy: the potential for the sleeve to dilate over time, which can reduce its long-term effectiveness.

For procedural context, readers may wish to refer to NICE Interventional Procedures Guidance IPG539 (Laparoscopic sleeve gastrectomy for obesity) and the NHS.uk weight loss surgery pages.

How the Fobi Ring Differs From Standard Sleeve Gastrectomy

Unlike standard sleeve gastrectomy, the Fobi ring adds a fixed point of narrowing intended to prevent sleeve dilation and improve long-term weight maintenance, but introduces additional risks including dysphagia, ring migration, and outlet obstruction.

The primary distinction between a Fobi ring gastric sleeve and a conventional sleeve gastrectomy lies in the addition of the fixed silicone ring. In a standard sleeve gastrectomy, restriction is achieved solely through the reduced stomach volume. Over time, some patients experience gradual stretching of the sleeve, which can contribute to weight regain. The Fobi ring is designed to counteract this by maintaining a consistent point of narrowing, even if the sleeve itself begins to expand.

From a physiological standpoint, it is hypothesised that the ring creates a two-chamber effect within the sleeve, whereby food entering the upper pouch is held briefly before passing through the ring into the lower portion. This is thought to enhance satiety signals and slow gastric emptying, though this mechanism remains incompletely characterised and should be regarded as a working hypothesis rather than an established fact.

Some studies and systematic reviews suggest that banded sleeve gastrectomy may offer improved weight maintenance at five to ten years compared with standard sleeve gastrectomy in certain patient groups. However, the evidence base remains limited and heterogeneous, and long-term comparative data from UK and European centres are still emerging. Results vary across surgical centres and patient populations, and patients should maintain realistic expectations.

The ring also introduces additional considerations that must be weighed carefully:

• Risk of outlet stenosis or obstruction at the ring, migration, or erosion into the gastric wall

• Higher rates of dysphagia and vomiting compared with standard sleeve gastrectomy

• Potential worsening of gastro-oesophageal reflux in some patients

• Potential need for ring removal if complications arise or the ring is not tolerated

• Increased operative complexity compared with standard sleeve gastrectomy

Patients considering this procedure should discuss these differences thoroughly with their bariatric surgical team to ensure they understand both the potential advantages and the additional risks involved. If a problem with the silicone ring is suspected at any point, this can be reported via the MHRA Yellow Card Scheme, which accepts reports of suspected adverse incidents involving medical devices.

Eligibility Criteria and Referral Pathways

Eligibility follows NICE CG189, requiring a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with a significant comorbidity, after non-surgical interventions have failed; referral begins with the GP via tier 3 weight management services.

Eligibility for bariatric surgery in the UK, including the Fobi ring gastric sleeve, is guided primarily by NICE Clinical Guideline CG189 (Obesity: identification, assessment and management). Under these guidelines, bariatric surgery is generally considered for adults who meet the following criteria:

• BMI of 40 kg/m² or above, or

• BMI of 35–39.9 kg/m² with a significant obesity-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea

• All appropriate non-surgical interventions have been tried and have not achieved or maintained adequate, clinically beneficial weight loss

• The individual is fit for anaesthesia and surgery

• The individual commits to long-term follow-up

NICE CG189 also recommends that people with a BMI of 30–34.9 kg/m² with recent-onset type 2 diabetes may be considered for surgery in specialist centres. Importantly, for people of Asian family origin, NICE advises that lower BMI thresholds (reduced by approximately 2.5 kg/m²) should be considered, reflecting the higher metabolic risk at lower BMI in this group.

Referral typically begins with the patient's GP. In England, this involves referral to a tier 3 specialist weight management service, followed by assessment by a multidisciplinary team (MDT) — which may include a dietitian, psychologist, physician, and surgeon — before consideration of tier 4 surgical intervention. In Scotland, Wales, and Northern Ireland, equivalent pathways exist through health boards; patients should check locally for specific arrangements.

Pre-operative optimisation is an important part of the pathway. This typically includes smoking cessation (ideally at least eight weeks before surgery), assessment and management of obstructive sleep apnoea, optimisation of diabetes and cardiovascular risk factors, and psychological readiness assessment. Specialist follow-up is usually provided for at least one to two years before transition to GP-led annual monitoring.

The Fobi ring gastric sleeve is not universally available on the NHS, and availability may vary by integrated care board (ICB) in England or equivalent commissioning body elsewhere. Some patients opt for this procedure through private bariatric surgery providers. Regardless of the funding route, thorough pre-operative psychological and nutritional assessment is considered essential. NICE does not have a separate recommendation specifically endorsing the banded sleeve variant over standard sleeve gastrectomy; the choice of procedure should be made collaboratively with the surgical team, taking into account individual circumstances.

Risks, Benefits, and Expected Outcomes

Benefits include significant weight loss and improvement of obesity-related comorbidities; specific Fobi ring risks include ring migration, outlet stenosis, and need for revisional surgery, with overall 30-day surgical mortality around 0.05–0.1% in UK specialist centres.

As with all bariatric procedures, the Fobi ring gastric sleeve carries both potential benefits and risks that must be carefully weighed on an individual basis.

The benefits associated with sleeve gastrectomy broadly include:

• Significant weight loss: typical excess weight loss (EWL) following standard sleeve gastrectomy is in the region of 50–60% at two years, though individual results vary; banded sleeve procedures may offer modestly improved weight maintenance in some patients over the longer term, though comparative UK data are still emerging

• Improvement or remission of obesity-related comorbidities, including type 2 diabetes, hypertension, dyslipidaemia, and obstructive sleep apnoea

• Improved quality of life, mobility, and psychological wellbeing

• Potential cardiovascular risk reduction over the long term

In terms of risks, those associated with sleeve gastrectomy in general include staple line leaks, bleeding, gastro-oesophageal reflux disease (GORD), nutritional deficiencies, and venous thromboembolism. The Fobi ring introduces additional specific risks:

• Outlet stenosis or obstruction at the ring

• Ring migration or erosion into the gastric wall

• Ring intolerance, causing dysphagia, persistent vomiting, or worsening reflux

• Need for revisional surgery to remove or reposition the ring

Overall 30-day surgical mortality for elective bariatric procedures in specialist UK centres is low — contemporary data from the National Bariatric Surgery Registry (NBSR) suggest figures in the region of 0.05–0.1% — though individual risk should be assessed by the MDT prior to proceeding.

Patients should seek urgent medical attention if they experience persistent vomiting, severe abdominal pain, difficulty swallowing, chest pain, or signs of infection following surgery. For urgent concerns, contact your surgical team directly or call NHS 111. Call 999 or go to the nearest emergency department immediately if you experience severe chest pain, shortness of breath, or signs of shock (such as feeling faint, cold, or clammy). These may indicate serious complications — including pulmonary embolism or anastomotic leak — requiring prompt assessment.

Recovery, Aftercare, and Dietary Guidance

Most patients are discharged within two to three days, following a staged dietary progression from clear fluids to normal food over eight to ten weeks, with lifelong nutritional supplementation and regular blood monitoring mandatory per BOMSS guidance.

Recovery following a Fobi ring gastric sleeve procedure follows a similar trajectory to standard sleeve gastrectomy, though the presence of the ring may influence dietary tolerance, particularly in the early post-operative period. Most patients are discharged from hospital within two to three days, provided there are no complications.

Dietary progression is carefully staged and should follow the protocol provided by your specialist bariatric dietitian, as schedules vary between centres. The following is a general guide only:

• Weeks 1–2: Clear fluids only, sipped slowly throughout the day

• Weeks 3–4: Full fluids, including smooth soups, milk, and protein shakes

• Weeks 5–6: Puréed foods, ensuring adequate protein intake

• Weeks 7–8: Soft, moist foods introduced gradually

• From week 8–10 onwards: Gradual return to a normal, balanced diet with small portions

Because the Fobi ring creates an additional point of restriction, eating too quickly or consuming foods of the wrong texture may cause discomfort, regurgitation, or vomiting. Chewing food thoroughly and eating slowly are essential habits to develop. Aim for approximately 60–80 g of protein per day and at least 1.5–2 litres of fluid daily (sipped between meals rather than with food). Carbonated drinks, high-sugar foods, and alcohol should be avoided or minimised long-term. NSAIDs (such as ibuprofen) should be avoided after bariatric surgery due to the risk of ulceration; discuss pain relief with your surgical team. A short course of a proton pump inhibitor (PPI) is commonly prescribed post-operatively per centre protocol.

If persistent vomiting occurs at any stage, seek prompt review from your bariatric team, as thiamine (vitamin B1) supplementation may be required to prevent Wernicke's encephalopathy — a serious neurological complication associated with prolonged vomiting and poor nutritional intake.

Nutritional supplementation is mandatory following sleeve gastrectomy and should be continued indefinitely. In line with BOMSS (British Obesity and Metabolic Surgery Society) guidance, patients are typically advised to take:

• A complete bariatric A–Z multivitamin and mineral supplement (lifelong)

• Calcium with vitamin D (dose as directed by your dietitian)

• Iron supplementation as indicated by blood results

• Vitamin B12 — often given as intramuscular injections every three months, or as directed

• Folic acid as directed, particularly important for women of childbearing age

Regular blood tests to monitor nutritional status are recommended at three months, six months, and annually thereafter. Monitoring should include full blood count, ferritin and iron studies, vitamin B12, folate, vitamin D, calcium, parathyroid hormone (PTH), urea and electrolytes, liver function tests, and HbA1c (for patients with diabetes). Zinc, copper, and selenium levels may be checked if symptoms suggest deficiency. Patients should contact their GP or bariatric team if they experience persistent nausea, hair loss, fatigue, numbness or tingling, or other signs of nutritional deficiency.

Women of childbearing age should use effective contraception and are advised to avoid pregnancy for at least 12–18 months following surgery, when weight loss is most rapid and nutritional status may be less stable. Those planning a pregnancy after this period should discuss this with their bariatric team and GP, and refer to RCOG guidance on pregnancy after bariatric surgery.

Long-Term Weight Loss and Follow-Up Support

Long-term success requires sustained lifestyle change, annual GP-led nutritional monitoring, and ongoing bariatric team access; the ring may help preserve weight loss at five to ten years, though evidence remains evolving.

Long-term success following a Fobi ring gastric sleeve depends not only on the surgical outcome but also on sustained behavioural change, ongoing nutritional support, and regular follow-up. Studies examining banded sleeve gastrectomy suggest that the addition of a ring may help to preserve weight loss at five to ten years post-operatively, with some data indicating a reduction in weight regain compared with unbanded sleeve gastrectomy. However, the evidence base remains evolving, and patients should maintain realistic expectations.

In the UK, specialist bariatric follow-up is typically provided for one to two years following surgery, after which ongoing monitoring transitions to GP-led annual review, with re-referral to the bariatric team if concerns arise. Follow-up care should include:

• Regular review appointments with the bariatric team during the first one to two years, including dietary and psychological support

• Annual GP-led monitoring thereafter, including blood tests for nutritional deficiencies (full blood count, iron studies, vitamin B12, folate, vitamin D, calcium, PTH, HbA1c for those with diabetes, and trace elements if indicated), weight review, and comorbidity management

• Bone health monitoring over the longer term, particularly in those at higher risk

• Ongoing GP involvement for medication review and general health monitoring — some medications may need dose adjustment as weight changes

• Access to psychological support if needed, particularly for those experiencing difficulties with body image, eating behaviours, or mental health

Weight regain can occur in a minority of patients, particularly if dietary habits revert or if the sleeve dilates over time. In such cases, the bariatric team may consider revisional procedures, though these carry higher surgical risk.

Women who become pregnant following bariatric surgery should inform their obstetric team of their surgical history. Enhanced nutritional monitoring and supplementation during pregnancy are recommended; RCOG provides specific guidance on the management of pregnancy after bariatric surgery.

Patients are encouraged to engage with peer support groups and community resources. Patient organisations such as WLSinfo and Obesity UK offer peer support and information. BOMSS provides professional guidance and resources relevant to bariatric care in the UK, and NHS bariatric services may also signpost local support.

Ultimately, the Fobi ring gastric sleeve is a tool to support weight management — not a standalone solution. Long-term success is most reliably achieved when surgery is combined with sustained lifestyle modification, nutritional vigilance, and proactive engagement with follow-up care. Patients with concerns about their progress or health should not hesitate to contact their GP or bariatric team for guidance. Suspected problems with the silicone ring device can be reported to the MHRA via the Yellow Card Scheme.

Frequently Asked Questions